Bioavailability Study of 6 Mercaptopurine in Crohns Disease Patients
- Study Title
- Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients
- Teva Identifier
- C1/13/6MP-02
- ClinicalTrials.gov Identifier
- NCT00774982
- Study Status
- Completed
- Trial Condition(s)
- Crohns Disease
- Interventions
- Drug: Delayed Release 6 mercaptopurine | Drug: 6 Mercaptopurine
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 50 Years
- Trial Duration
- 12/01/2008 - 02/01/2009
- Phase
- Phase 1
